As of 11:08am ET
| -0.14 / -4.46%|
The 2 analysts offering 12-month price forecasts for Apricus Biosciences Inc have a median target of 4.93, with a high estimate of 7.00 and a low estimate of 2.85. The median estimate represents a +64.17% increase from the last price of 3.00.
The current consensus among 2 polled investment analysts is to Buy stock in Apricus Biosciences Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.